Dearbhaile M. O’Donnell

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Nicoletta Colombo, Cristiana Sessa, Andreas du Bois et al. · Annals of Oncology · 2019 · 1.1K citations · Full text

Borderline Tumours, Tumoral Pathology, Medicine +9

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

Andrew R. Clamp, Elizabeth C James, Iain A. McNeish et al. · The Lancet · 2019 · 213 citations · Full text

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Christopher J. Sweeney, Andrew Martin, Martin R. Stockler et al. · The Lancet Oncology · 2023 · 175 citations

Urology, Oncology, Genitourinary Cancer +7

Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming

Alison Merrick, Kate Milward, Dearbhaile M. O’Donnell et al. · British Journal of Cancer · 2005 · 125 citations · Full text

A novel serum microRNA panel to discriminate benign from malignant ovarian disease

Ream Langhe, Lucy Norris, Feras Abu Saadeh et al. · Cancer Letters · 2014 · 81 citations · Full text

Endocrine-related Cancer, Medicine, Pathology +8